MAP Study: Methotrexate and Adalimumab in Psoriasis
Clinical trial NCT03217734 · COMPLETED
Trial details
- NCT number
- NCT03217734
- Sponsor
- Jeffrey J Crowley MD
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2018-12-31
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.